Metropolitan Life Insurance Company (MetLife)’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio CHTP Stock Details CHTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-60,652	Closed	-$139K	–	2849
2014 Q1	$139K	Hold	60,652	–	–	﹤0.01%	2617
2013 Q4	$269K	Hold	60,652	–	–	﹤0.01%	2269
2013 Q3	$183K	Buy	+60,652	New	+$174K	﹤0.01%	2487

Other funds holding CHTP

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.82% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s CHTP Position: Q2 2014 in Review

Metropolitan Life Insurance Company (MetLife) sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q2 2014, closing a stake of 60,652 shares — an estimated $139K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CHTP in Q3 2013 and held it in 3 quarters. The position peaked at $269K in Q4 2013. 6 funds tracked by Wall St. Rank hold CHTP as of Q2 2014.

Metropolitan Life Insurance Company (MetLife) reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q2 2014 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 60,652 CHELSEA THERAPEUTICS INT'L LTD shares in Q2 2014, an estimated $139K.
Metropolitan Life Insurance Company (MetLife) first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q3 2013 and held it in 3 quarters.
Metropolitan Life Insurance Company (MetLife)'s CHELSEA THERAPEUTICS INT'L LTD position peaked at $269K in Q4 2013.
6 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q2 2014.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2014, filed 31 Jul 2014.